Published: May, 2018

A recent report by Transparency Market Research on the substance abuse treatment market in the U.S. states that the competitive landscape is highly fragmented. This is because around 242 companies compete against one another in it. This also makes overall competition stiff. Some of the companies that have beat competition to emerge as leading players in the market are Pfizer Inc., Alkermes Plc, GlaxoSmithKline Plc., and Purdue Pharma LP. Their astute marketing strategies have helped to enhance their market shares majorly.

Our report, which valued the U.S. market for substance abuse treatment at US$4.42 bn in 2015, estimates it to become worth US$12.43 bn by 2024-end by rising at an impressive 12.40% CAGR between 2016 and 2024.

us substance abuse treatment marketThe most prevalent substance abuse in the U.S. are those pertaining to tobacco or nicotine addiction, alcohol dependence, and opioid addiction. Among them, the tobacco or nicotine addiction leads owing to around 15.0% of people in the nation being addicted to smoking. When it comes to end users, the outpatient treatment centers are responsible for driving most of the demand mainly because their rising popularity. In the years ahead too, the segment will drive most of the demand in the market.

Alarming Rise in Cases of Substance Abuse Drives Market

At the forefront of driving the market for substance abuse treatment in the U.S. is the spike in number of alcohol, opioid, and nicotine or tobacco addicts. “The federal government along with the local authorities in the nation have devised myriad early intervention and therapeutic strategies to bring the situation under control. This is expected to bode well for the market for substance abuse treatment in the near term,” states the lead analyst of TMR.

In addition, the U.S. market for substance abuse is also expected to gain from the leading companies’ efforts to enhance their customer base by generating awareness through campaigns about the harmful effects of drug abuse and the necessity of timely treatment. In order to do so, the companies are seen banking upon every medium including print, television, and online.

Strict Approval Process for New Therapies Offsets Market Growth to an Extent

On the flipside, not too many therapies for mental illness resulting from substance addiction and stringent rules pertaining to approval of therapies is dampening market growth to an extent.

The most widely sold drugs in the market for substance abuse treatment market are disulfiram, naltrexone, and acamprosate. Among them, acamprosate will likely see maximum share in the near future. Non-nicotine medications and nicotine replacement treatment have now emerged as the most effective treatments for nicotine and tobacco addiction.

This review is based on the findings of a TMR report, titled, “Substance Abuse Treatment Market (Abuse Type - Alcohol Dependence, Tobacco/Nicotine Addiction, and Opioid Addiction; Treatment Type - Alcohol Addiction Treatment (Disulfiram, Acamprosate, and Naltrexone), Tobacco/Nicotine Addiction Treatment (Nicotine Replacement Treatment and Non-nicotine Medication), Drug Abuse Treatment (Methadone, Buprenorphine, and Naltrexone); End User - Outpatient Treatment Centers, Residential Treatment Centers, and Inpatient Treatment Centers) - U.S. Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016–2024.”

The report segments the U.S. Substance Abuse Treatment Market into the following:

The U.S. Substance Abuse Treatment Market, by Abuse Type

  • Alcohol Dependence
  • Tobacco/Nicotine Addiction
  • Opioid Addiction 

The U.S. Substance Abuse Treatment Market, by Treatment

  • Alcohol Addiction Treatment
    • Disulfiram
    • Acamprosate
    • Naltrexone
  • Tobacco/Nicotine Addiction Treatment
    • Nicotine Replacement Treatment
      • Nicotine Patch
      • Nicotine Gum
      • Nicotine Lozenge
      • Nicotine Spray
      • Nicotine Inhaler
    • Non-Nicotine Medication
      • Bupropion
      • Varenicline
  • Drug Abuse Treatment
    • Methadone
    • Buprenorphine
    • Naltrexone 

The U.S. Substance Abuse Treatment Market, by End User

  • Outpatient Treatment Centers
  • Residential Treatment Centers
  • Inpatient Treatment Centers 

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact Us

Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States

Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com